Can talking about their problems help men forge closer relationships – or is there another way? Josh Halliday reports Josh Halliday is 37, and not short of friends. There are his two closest mates, and then the big group who meet up for weekends away. But recently the Guardian’s north of England editor has noticed something. “My relationship with my two closest friends, who I’ve been friends with ...
Can talking about their problems help men forge closer relationships – or is there another way? Josh Halliday reports Josh Halliday is 37, and not short of friends. There are his two closest mates, and then the big group who meet up for weekends away. But recently the Guardian’s north of England editor has noticed something. “My relationship with my two closest friends, who I’ve been friends with now for 15-16 years, has been fairly surface level, to be honest – 90% of our chat is probably football-related, always with a drink in hand. If you asked me to name their immediate family, I wouldn’t be able to do it. And I think that’s quite shocking really.” Continue reading...
Funtap/iStock via Getty Images Key takeaways 1 The fund outperformed its benchmark Stock selection in information technology ('IT') drove outperformance in the fourth quarter. Conversely, stock selection in health care and financials detracted from relative return. 2 We capitalized
Funtap/iStock via Getty Images Key takeaways 1 The fund outperformed its benchmark Stock selection in information technology ('IT') drove outperformance in the fourth quarter. Conversely, stock selection in health care and financials detracted from relative return. 2 We capitalized
Earnings Call Insights: Definium Therapeutics (DFTX) Q4 2025 Management View CEO Robert Barrow highlighted, "We are incredibly excited to share today's updates as we rapidly approach our anticipated pivotal readouts for lysergide tartrate or DT120 ODT in generalized anxiety disorder and
Earnings Call Insights: Definium Therapeutics (DFTX) Q4 2025 Management View CEO Robert Barrow highlighted, "We are incredibly excited to share today's updates as we rapidly approach our anticipated pivotal readouts for lysergide tartrate or DT120 ODT in generalized anxiety disorder and
Earnings Call Insights: NetApp, Inc. (NTAP) Q3 2026 Management View CEO George Kurian opened the call highlighting a strong quarter, reporting "Q3 revenue of $1.71 billion, an increase of 4% year-over-year. Excluding the divested Spot business, total revenue was up 6%." He pointed to accelerating growth and record
Earnings Call Insights: NetApp, Inc. (NTAP) Q3 2026 Management View CEO George Kurian opened the call highlighting a strong quarter, reporting "Q3 revenue of $1.71 billion, an increase of 4% year-over-year. Excluding the divested Spot business, total revenue was up 6%." He pointed to accelerating growth and record